<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-19722" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Colon Cancer Screening</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kumar</surname>
            <given-names>Rahul</given-names>
          </name>
          <aff>Sharda Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lewis</surname>
            <given-names>Catherine R.</given-names>
          </name>
          <aff>Norton Community Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Rahul Kumar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Catherine Lewis declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>10</day>
          <month>9</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-19722.s1" sec-type="Definition/Introduction">
        <title>Definition/Introduction</title>
        <p content-type="pubmed-excerpt">Colorectal carcinoma (CRC) is the third most common non-skin cancer in the United States (US) after lung cancer in both men and women, with an annual incidence of 42.9 per 100,000 people. CRC accounts for 8% of cancer-related deaths in the US alone.<xref ref-type="bibr" rid="article-19722.r1">[1]</xref>&#x000a0; The&#x000a0;prevalence and incidence of CRC vary worldwide, with Australia and New Zealand having the highest incidence, followed by North America and Europe. Africa and South-Central Asia have the lowest incidence. Such a pattern only extrapolates that CRC incidence is attributed to dietary factors along with genetic and environmental factors. This condition also displays a strong correlation with increased age, with the maximum rate at the age above 75 years and the lowest below 40 years. Men are affected more than females. Blacks have the highest incidence, and Asian Pacific Islanders have the lowest. Screening is the process of looking for cancer in patients who have no symptoms. Several tests are available to screen for colorectal cancer. These tests can be divided into stool-based tests and visual exams. Any abnormal test result should be followed up with a colonoscopy. If cancer of the colon is caught early, the patient usually has a better outcome.</p>
      </sec>
      <sec id="article-19722.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>With the advent of newer and better screening tools, the CRC-related mortality rate has decreased, on average, by about 2.7% between 2004 and 2013. This number is expected to decrease further to about 38% for 50 to 74-year-olds and about 45% for those older than 75 by 2030.<xref ref-type="bibr" rid="article-19722.r2">[2]</xref>&#x000a0;However, for unknown reasons, data from the United States Surveillance, Epidemiology, and End Results (SEER) database suggests that the incidence has been increasing among younger adults below 50 years of age.<xref ref-type="bibr" rid="article-19722.r3">[3]</xref>&#x000a0;Rates have increased constantly at a rate of 2 percent yearly from 1992 through 2013.<xref ref-type="bibr" rid="article-19722.r3">[3]</xref>&#x000a0;Hence, delivering more effective and robust screening is the best preventive instrument.&#x000a0;</p>
        <p>Recently, a gradual shift towards right-sided or proximal colon cancers has been seen both in the United States and internationally.<xref ref-type="bibr" rid="article-19722.r4">[4]</xref><xref ref-type="bibr" rid="article-19722.r5">[5]</xref>&#x000a0;Mostly, the incidence of&#x000a0;cecal primary malignancies has increased.<xref ref-type="bibr" rid="article-19722.r6">[6]</xref>&#x000a0;This can be attributed to the anatomic distribution of CRCs as well as to improvements in diagnosis and treatment by screening and removal of adenomatous polyps in the distal colon. Cancer biology also seems to play a role in this recent shift since serrated adenomas, which exclusively have&#x000a0;<italic toggle="yes">BRAF-</italic>V600E mutations, cause lesions that are flatter and difficult to visualize endoscopically and are more common in the right colon.<xref ref-type="bibr" rid="article-19722.r7">[7]</xref>&#x000a0;Wide-spread, compliant, and flexible screening is the best step to prevent CRC mortality in the near future, given the present epidemiological evidence.&#x000a0;</p>
        <p>
<bold>Pathogenesis</bold>
</p>
        <p>Most CRCs begin as protuberances tethered to the inner surface of the colon or rectum, clinically known as &#x0201c;polyps.&#x0201d; These are mainly of two types: flat or raised, relative to the inner-epithelial lining. Raised polyps show two distinctive growth patterns of mushroomed growth:</p>
        <list list-type="bullet">
          <list-item>
            <p>With a stalk (pedunculated polyps)</p>
          </list-item>
          <list-item>
            <p>Without a stalk (sessile polyps)</p>
          </list-item>
        </list>
        <p>About 10% of patients with CRC carry 1 or more pathogenic &#x0201c;non-Lynch syndrome mutations,&#x0201d;&#x000a0; including mutations in high-penetrance genes such as <italic toggle="yes">APC</italic>, bi-allelic&#x000a0;<italic toggle="yes">MUTYH,&#x000a0;BRCA1, BRCA2,&#x000a0;PALB2,&#x000a0;CDKN2A</italic>, and&#x000a0;<italic toggle="yes">TP53</italic>.<xref ref-type="bibr" rid="article-19722.r8">[8]</xref>&#x000a0;Right-sided CRCs tend to be diagnosed in advanced stages compared to left-sided, as the cecum and right colon have a larger caliber, and stool is more liquid,&#x000a0;causing fewer symptoms of partial obstruction such as pain, swelling, and constipation. Blood in stools (hematochezia or melena) isn&#x02019;t readily observed and comes much later as compared to the left side, making screening tools pivotal in management for early detection and therapy.<xref ref-type="bibr" rid="article-19722.r8">[8]</xref><xref ref-type="bibr" rid="article-19722.r7">[7]</xref></p>
        <p>
<bold>Risk factors for CRC</bold>
</p>
        <p>Risk factor assessments help to categorize the patient as high, average, or low-risk. Aggressive multiple interval-based testing starts as early as the teenage years in patients with a positive family history or co-existing genetic cancer syndromes.&#x000a0;A relaxed approach toward screening and further management&#x000a0;can be seen in the majority of cases who are at average risk.<xref ref-type="bibr" rid="article-19722.r9">[9]</xref><xref ref-type="bibr" rid="article-19722.r10">[10]</xref></p>
        <p>Family history (especially first-degree relatives)</p>
        <list list-type="bullet">
          <list-item>
            <p>Colorectal carcinoma</p>
          </list-item>
          <list-item>
            <p>Pre-cancerous adenomas</p>
          </list-item>
        </list>
        <p>Genetic cancer syndromes</p>
        <list list-type="bullet">
          <list-item>
            <p>Familial adenomatous polyposis (FAP) (and its variants Gardner and Turcot syndrome)</p>
          </list-item>
          <list-item>
            <p>Lynch syndrome</p>
          </list-item>
          <list-item>
            <p>Hereditary non-polyposis colorectal cancer (HNPCC)</p>
          </list-item>
          <list-item>
            <p>Peutz-Jeghers syndrome</p>
          </list-item>
          <list-item>
            <p>Juvenile polyposis&#x000a0;</p>
          </list-item>
        </list>
        <p>Medical history</p>
        <list list-type="bullet">
          <list-item>
            <p>Previously resected or diagnosed adenomatous colorectal polyps; or any of the above-mentioned genetic cancer syndromes</p>
          </list-item>
          <list-item>
            <p>Cystic fibrosis&#x000a0;<xref ref-type="bibr" rid="article-19722.r11">[11]</xref></p>
          </list-item>
          <list-item>
            <p>Inflammatory bowel diseases like Crohn disease or ulcerative colitis</p>
          </list-item>
          <list-item>
            <p>Diabetes mellitus and insulin resistance&#x000a0;<xref ref-type="bibr" rid="article-19722.r12">[12]</xref></p>
          </list-item>
          <list-item>
            <p>Abdomino-pelvic radiation for an earlier cancer in childhood or adolescence (as&#x000a0;suggested by Children Oncology Group)</p>
          </list-item>
          <list-item>
            <p>Human immunodeficiency virus infection in men&#x000a0;<xref ref-type="bibr" rid="article-19722.r13">[13]</xref></p>
          </list-item>
        </list>
        <p>Personal history</p>
        <list list-type="bullet">
          <list-item>
            <p>Chronic alcohol use disorder</p>
          </list-item>
          <list-item>
            <p>Smoking</p>
          </list-item>
          <list-item>
            <p>Physical inactivity</p>
          </list-item>
          <list-item>
            <p>Obesity</p>
          </list-item>
          <list-item>
            <p>Poor diet (low fiber; high amounts of red and processed meat consumption)</p>
          </list-item>
        </list>
        <p>Race</p>
        <list list-type="bullet">
          <list-item>
            <p>Higher incidence and mortality among Blacks particularly men. CRC occurrence is higher in Black individuals less than 50 years of age. Hence earlier screening, starting from the age of 45 years, is recommended by the US Preventive Services Task Force (USPSTF).<xref ref-type="bibr" rid="article-19722.r1">[1]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19722.s3" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>
<bold>Screening Tools</bold>
</p>
        <p>The various modalities for early detection of CRCs are as follows:</p>
        <p>
<bold>Stool-Based Tests</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Fecal immuno-chemical test (FIT)</p>
          </list-item>
          <list-item>
            <p>Guaiac fecal occult blood test (gFOBT), also known as HSgFOBT (high-sensitivity guaiac-based fecal occult blood test)</p>
          </list-item>
          <list-item>
            <p>Stool deoxyribonucleic acid (DNA) test (FIT-DNA): also known as &#x000a0;multi-targeted-stool DNA test (MT-sDNA)&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Visualization-Based Tests</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Sigmoidoscopy</p>
          </list-item>
          <list-item>
            <p>Colonoscopy
<list list-type="bullet"><list-item><p>Optical: standard&#x000a0;</p></list-item><list-item><p>Virtual: radiological; CTC and capsule colonoscopy</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Barium enema&#x000a0; &#x000a0; &#x000a0; &#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Blood-Based Test</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Methylated <italic toggle="yes">SEPT-9</italic></p>
          </list-item>
        </list>
        <p>
<bold>Age to Initiate Screening</bold>
</p>
        <p>The USPSTF and many other expert councils recommend initiating screening for average-risk patients at 45 years of age due to high early-onset incidence.<xref ref-type="bibr" rid="article-19722.r1">[1]</xref>&#x000a0;For those with high-risk attributes (positive family history or cancer syndromes), screening can be initiated as early as the teenage years.<xref ref-type="bibr" rid="article-19722.r9">[9]</xref>&#x000a0;Screening for those with a positive family history is recommended to start 10 years before the age of diagnosis of the family member. USPSTF doesn't recommend routine CRC screening in adults 86 years and older.</p>
        <p>
<bold>Contraindications for Screening</bold>
</p>
        <p>Contraindications might vary depending on the screening method. Most stool-based tests can be carried out easily. However, other screening methods involve sedation, consumption of contrast, and further instrumentation of the colon. Bowel preparation is a vital prerequisite, using either a laxative or non-laxative method. The type of bowel preparation should be determined based on the patient's medical conditions. Colonoscopy should generally be avoided if there is a concern for bowel perforation. Care should be taken for the following conditions:&#x000a0;&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Active colonic inflammation (eg, acute diarrhea, active inflammatory bowel disease)</p>
          </list-item>
          <list-item>
            <p>Symptomatic colon-containing abdominal wall hernia</p>
          </list-item>
          <list-item>
            <p>Recent acute diverticulitis</p>
          </list-item>
          <list-item>
            <p>Recent colorectal surgery</p>
          </list-item>
          <list-item>
            <p>Recent deep endoscopic biopsy/polypectomy/mucosectomy</p>
          </list-item>
          <list-item>
            <p>Known or suspected colonic perforation</p>
          </list-item>
          <list-item>
            <p>Symptomatic or high-grade bowel obstruction&#x000a0;</p>
          </list-item>
          <list-item>
            <p>The patient is unwilling to give consent</p>
          </list-item>
          <list-item>
            <p>The patient is uncooperative or unable to achieve sedation&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Risk of colonic perforation in patients undergoing colonoscopies, such as those with toxic mega-colon and fulminant colitis&#x000a0;<xref ref-type="bibr" rid="article-19722.r14">[14]</xref></p>
          </list-item>
          <list-item>
            <p>Other contraindications limited to colonoscopy include inadequate bowel preparation, recent myocardial infarction, arrhythmias, or medically unstable patients</p>
          </list-item>
        </list>
        <p>
<bold>Evidence of Effectiveness of Various Screening Tests:</bold>
</p>
        <p>
<bold>Guaiac FOBT vs F</bold>
<bold>ecal Immune-chemical Test&#x000a0;</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>FIT is more sensitive than gFOBT for colon lesions.<xref ref-type="bibr" rid="article-19722.r15">[15]</xref></p>
          </list-item>
          <list-item>
            <p>High-sensitivity gFOBT&#x000a0;has a sensitivity of 62% to 79% and a specificity of 87% to 96% for detecting colorectal cancer.<xref ref-type="bibr" rid="article-19722.r16">[16]</xref></p>
          </list-item>
          <list-item>
            <p>FIT has a sensitivity of 79% to 88% and a specificity of 91% to 93%.</p>
          </list-item>
          <list-item>
            <p>Evidence suggests a decline in the mortality rate by 15% to 33% when gFOBT/FIT is performed every 1 to 2 years in people 50&#x000a0;to 80 years.<xref ref-type="bibr" rid="article-19722.r16">[16]</xref></p>
          </list-item>
          <list-item>
            <p>FIT has high sensitivity (80%) for detecting CRC, while only 25% to 56% sensitivity is for detecting advanced adenomas.<xref ref-type="bibr" rid="article-19722.r16">[16]</xref><xref ref-type="bibr" rid="article-19722.r17">[17]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Stool DNA Test</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>The sensitivity and specificity were 92% to 95% and 84% to 95%, respectively. This test's sensitivity to detect advanced precancerous lesions such as advanced adenomas and sessile serrated polyps measuring less than 1 cm was 42% and its specificity to detect "all nonadvanced findings," including non-neoplastic findings, was 87%.<xref ref-type="bibr" rid="article-19722.r18">[18]</xref></p>
          </list-item>
          <list-item>
            <p>This test displays a higher sensitivity than FIT (92% vs 74%), with more false positives. However, it detected less than half of advanced adenomas (42%), limiting its preventive role due to its low specificity (87% to 90%).<xref ref-type="bibr" rid="article-19722.r19">[19]</xref></p>
          </list-item>
          <list-item>
            <p>No evidence of mortality reduction currently exists.&#x000a0; &#x000a0;&#x000a0;&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Sigmoidoscopy</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Evidence suggests that regular screening with sigmoidoscopy alone after 50 years (55 to 64 years) significantly lowers mortality related to rectal or lower colonic cancer by 60% to 70%.<xref ref-type="bibr" rid="article-19722.r20">[20]</xref><xref ref-type="bibr" rid="article-19722.r21">[21]</xref></p>
          </list-item>
          <list-item>
            <p>There is a reduction of CRC incidence by 33% to 42% through various randomized controlled trials.<xref ref-type="bibr" rid="article-19722.r20">[20]</xref><xref ref-type="bibr" rid="article-19722.r22">[22]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Colonoscopy</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>The reduction in CRC incidence and mortality was 31% and 46%, respectively, as established by 6 observational studies, which further suggested strong evidence of a reduction in incidence and mortality of both distal and proximal colorectal cancers. Sigmoidoscopy only helps in curtailing distal CRC-related mortality and incidence.<xref ref-type="bibr" rid="article-19722.r7">[7]</xref></p>
          </list-item>
          <list-item>
            <p>Colonoscopy is more effective in preventing left-sided CRCs than right-sided CRCs, which could also contribute to a shift in the distribution of cancers in the colon.<xref ref-type="bibr" rid="article-19722.r7">[7]</xref>&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>The sensitivity of colonoscopy after bowel preparation to detect adenomas 6 mm or larger ranged from 75% to 93%, and specificity ranged from 89% to 91%.<xref ref-type="bibr" rid="article-19722.r23">[23]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>For adenomatous polyps 6 mm or larger, a systematic review reported the sensitivity of colonoscopy for detection varied from 75% to 93%. The miss rate for polyps of any size was 22%, with rates increasing inversely with the size of the lesion. Adenomas smaller&#x000a0;than 5 mm&#x000a0;were missed in as many as 25% of patients.<xref ref-type="bibr" rid="article-19722.r24">[24]</xref><xref ref-type="bibr" rid="article-19722.r25">[25]</xref><xref ref-type="bibr" rid="article-19722.r26">[26]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Colon Capsule Endoscopy</bold>
</p>
        <p>Study results showed that in patients who are asymptomatic using high-quality optic colonoscopy as the standard, capsule endoscopy identified subjects with more than one adenoma of greater than or equal to 6 mm with a sensitivity of 88% and specificity of 82%, and even higher rates in larger adenomas.<xref ref-type="bibr" rid="article-19722.r27">[27]</xref></p>
        <p>
<bold>Computed Tomography Colonography</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Even though it's a sophisticated modality when compared to colonoscopy, multiple studies demonstrate a fluctuating sensitivity for CRC lesions, between 67% and 94%, while colonoscopy is 92% sensitive. However, CT colonography (CTC) has a very high specificity at 96% to 98%.<xref ref-type="bibr" rid="article-19722.r28">[28]</xref></p>
          </list-item>
          <list-item>
            <p>Patients who underwent both colonoscopy and CTC saw a surge of 14 to 15 non-rectal neoplasms, missed by colonoscopy, which were located on mucosal folds.<xref ref-type="bibr" rid="article-19722.r29">[29]</xref><xref ref-type="bibr" rid="article-19722.r25">[25]</xref></p>
          </list-item>
          <list-item>
            <p>This test can still miss some flattened and small polyps (less than 8 mm).<xref ref-type="bibr" rid="article-19722.r29">[29]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Methylated <italic toggle="yes">SEPT-9</italic></bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>This can detect advanced&#x000a0;CRC; however, relevance in early-stage detection is yet to be established.&#x000a0;The methylated <italic toggle="yes">SEPT-9</italic> DNA assay has a sensitivity for CRC of 75% and specificity of 87%, with increasing detection rates in advanced cancers.<xref ref-type="bibr" rid="article-19722.r30">[30]</xref></p>
          </list-item>
          <list-item>
            <p>Due to poor sensitivity, its role as a primary screening tool is questionable. This test also has a false positive rate of 4.7%.<xref ref-type="bibr" rid="article-19722.r31">[31]</xref><xref ref-type="bibr" rid="article-19722.r30">[30]</xref></p>
          </list-item>
          <list-item>
            <p>There is no evidence yet that this test can reduce CRC deaths. However, as a non-invasive testing option, it can have significantly increased compliance and participation among high-risk groups.<xref ref-type="bibr" rid="article-19722.r30">[30]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Screening Protocols and Algorithms&#x000a0;</bold>
</p>
        <p>
<bold>Fecal Occult Blood Test</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Since polyps and CRCs have a high propensity to bleed, FOBT can detect occult blood.<xref ref-type="bibr" rid="article-19722.r19">[19]</xref></p>
          </list-item>
          <list-item>
            <p>Sample collection: The patient is given a stool collection kit or asked to get one from the pharmacy (as per local protocols) and is asked to bring in stool samples (sometimes by mail) within 24 hours of collection, as sensitivity to test declines proportionally to delay.<xref ref-type="bibr" rid="article-19722.r32">[32]</xref><xref ref-type="bibr" rid="article-19722.r33">[33]</xref></p>
          </list-item>
          <list-item>
            <p>Sample processing: Don't rehydrate samples, as it may falsely increase sensitivity, leading to an increased number of false positives.<xref ref-type="bibr" rid="article-19722.r33">[33]</xref>&#x000a0;&#x000a0;</p>
          </list-item>
        </list>
        <p><bold>Guaiac FOBT:</bold>&#x000a0;This test uses guaiac as the main reagent, a plant that grows exclusively in the Caribbean. It detects organic heme by oxidation. Therefore, the presence of dietary heme from red meat, peroxidase from some plants, and anti-oxidants like vitamin C or E can&#x000a0;lead to false positives. Fasting is advised before the test.</p>
        <p><bold>Fecal Immune-Chemical Test:</bold>&#x000a0;This test employs antibodies to specifically detect human heme-based globin. Dietary and medication restrictions prior to the test aren't required. The test is very specific for detecting colonic/rectal bleeding.</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Advantages</bold>
<list list-type="bullet"><list-item><p>Bowel preparation isn't a prerequisite.</p></list-item><list-item><p>Dietary or medication restrictions are&#x000a0;not&#x000a0;a prerequisite for FIT. Samples can be collected at home, hence convenience and higher adherence.<xref ref-type="bibr" rid="article-19722.r34">[34]</xref></p></list-item><list-item><p>Cost-effective compared to other CRC screening tests.</p></list-item><list-item><p>There is no risk of damage to the colon.&#x000a0;</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Disadvantages</bold>
<list list-type="bullet"><list-item><p>The test does not detect some&#x000a0;polyps and&#x000a0;cancers.</p></list-item><list-item><p>False-positive test results are possible.</p></list-item><list-item><p>Dietary restrictions are needed before guaiac FOBT.</p></list-item><list-item><p>Additional procedures, such as&#x000a0;colonoscopy, may be needed if the results are positive.&#x000a0;&#x000a0;</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>
<bold>Stool DNA Test</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Also known as the FIT-DNA test, it comes as a US Food and Drug Administration (FDA)-approved kit. This is a multi-target test that detects occult blood along with 9 DNA biomarkers of three genes associated with CRC and advanced adenoma.<xref ref-type="bibr" rid="article-19722.r8">[8]</xref><xref ref-type="bibr" rid="article-19722.r18">[18]</xref></p>
          </list-item>
          <list-item>
            <p>Sample collection: Like FOBTs, the patient is provided with a stool collection kit and asked to collect a stool sample, which can be delivered via mail or personally to a laboratory/office, ideally within 72 hours.</p>
          </list-item>
          <list-item>
            <p><bold>Advantages</bold>
<list list-type="bullet"><list-item><p>No bowel preparation is required.</p></list-item><list-item><p>No dietary or medication restrictions as a pre-requisite.</p></list-item><list-item><p>Samples can be collected at home, hence convenience and high adherence.</p></list-item><list-item><p>No risk of damage to the colon.&#x000a0;</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Disadvantages</bold>
<list list-type="bullet"><list-item><p>More expensive than gFOBT or FIT.</p></list-item><list-item><p>Test&#x000a0;sensitivity&#x000a0;for&#x000a0;adenomas&#x000a0;is low.</p></list-item><list-item><p>False-positive test results can be seen.</p></list-item><list-item><p>Additional procedures, such as colonoscopy, are advised if the results are positive. &#x000a0;</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>
<bold>Sigmoidoscopy</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Examination of the rectum and sigmoid colon using a sigmoidoscope, an instrument consisting of a flexible tube with a lens and light source for visualization and a tool for removing tissues (polyp/adenoma) or taking biopsy samples.</p>
          </list-item>
          <list-item>
            <p>The sigmoidoscope is inserted through the anus up to the splenic flexure after insufflating carbon dioxide for better visualization.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Advantages</bold>
<list list-type="bullet"><list-item><p>Minimal discomfort and complications&#x000a0;are rare.</p></list-item><list-item><p>Biopsy and polypectomy&#x000a0;(removal of a&#x000a0;polyp&#x000a0;or&#x000a0;adenoma) can be performed during the same procedure.&#x000a0;</p></list-item><list-item><p>Less extensive cleansing of the colon is required than for colonoscopy, as it only probes&#x000a0;the sigmoid colon.</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Disadvantages</bold>
<list list-type="bullet"><list-item><p>Pre-cancerous or CRC lesions in the right colon will be missed due to limited visualization.</p></list-item><list-item><p>Bowel&#x000a0;preparation by either enema or laxatives is a pre-requisite.</p></list-item><list-item><p>Medication and diet changes may be needed before the test.</p></list-item><list-item><p>Small risk of bleeding or perforation of the colon lining.</p></list-item><list-item><p>Additional procedures, such as colonoscopy, may be needed to detect synchronous lesions.</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>
<bold>Colonoscopy</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>A colonoscope&#x000a0;is inserted through the anus and through the entire colon ending in the cecum.</p>
          </list-item>
          <list-item>
            <p>Abnormal growths&#x000a0;can be visualized and can be either removed (polypectomy) in whole, or a small sample can be taken for biopsy in a single procedure.</p>
          </list-item>
          <list-item>
            <p>Since the procedure is more invasive than sigmoidoscopy, it requires rigorous bowel preparation and dietary modifications.<xref ref-type="bibr" rid="article-19722.r35">[35]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Advantages</bold>
<list list-type="bullet"><list-item><p>This is one of the most sensitive and definitive methods (the gold standard) currently available for the detection of pre-cancerous adenomas and CRC.</p></list-item><list-item><p>This allows for the best visualization of the cecum and the entire colon, unlike sigmoidoscopy.</p></list-item><list-item><p>Biopsy and polypectomy can be done in a single procedure.</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Disadvantages</bold>
<list list-type="bullet"><list-item><p>Even though this test is highly sensitive, it still may not detect all small or sessile polyps and cancers.</p></list-item><list-item><p>Thorough cleansing of the colon is a prerequisite.</p></list-item><list-item><p>Diet and medication modifications are prerequisites.</p></list-item><list-item><p>Some form of sedation is almost always used. Hence, the patient must have someone to accompany them. Rest and avoiding any work is advised after the procedure.&#x000a0;</p></list-item><list-item><p>Small risk of bleeding or perforation of the colon; this risk increases with age, with the presence of other health problems, and when polyps are removed.<xref ref-type="bibr" rid="article-19722.r14">[14]</xref></p></list-item></list>
</p>
          </list-item>
        </list>
        <p>
<bold>Colon Capsule&#x000a0;Endoscopy</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>This is FDA-approved for use only in patients who had an incomplete colonoscopy. The patient swallows a capsule containing tiny wireless cameras that take images as the capsule traverses the colon.</p>
          </list-item>
          <list-item>
            <p><bold>Advantages</bold>
<list list-type="bullet"><list-item><p>Colon capsule endoscopy requires bowel preparation; however, it does not require sedation or dietary or medication adjustments.</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Disadvantages</bold>&#x000a0;
<list list-type="bullet"><list-item><p>It doesn't accommodate polypectomy or biopsy and is only meant for lesion visualization. This test appears to have a sensitivity and specificity similar to colonoscopy. However,&#x000a0;it is not indicated as a primary screening tool.</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>
<bold>Computed Tomography Colonography</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>The procedure isn't invasive and doesn't require sedation. However, bowel preparation and carbon dioxide insufflation are still needed for better visualization.</p>
          </list-item>
          <list-item>
            <p>This may additionally require an intravenous catheter for glucagon administration for bowel relaxation. Images are then obtained during a single 32-second breath-hold.<xref ref-type="bibr" rid="article-19722.r28">[28]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Advantages</bold>
<list list-type="bullet"><list-item><p>A minimally invasive procedure, hence little to no risk of damage to the colon.</p></list-item><list-item><p>No sedation is required.</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Disadvantages</bold>
<list list-type="bullet"><list-item><p>Thorough cleansing of the colon is a pre-requisite.</p></list-item><list-item><p>This can miss small polyps.</p></list-item><list-item><p>Additional procedures, such as standard colonoscopy, are advised should CTC come back positive for lesions.&#x000a0;</p></list-item><list-item><p>This exposes an already at-risk patient to ionizing radiation and discomfort of contrast with possible allergy.&#x000a0;</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>
<bold>Fecal Tagging</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>It's a laxative-free CTC approach. The contrast agent is administered orally over several days before the procedure, making fecal material in the colon&#x000a0;distinct from colon tissue by "tagging" it.</p>
          </list-item>
          <list-item>
            <p>Radiographs of the colon are then obtained.</p>
          </list-item>
          <list-item>
            <p>Sensitivity is somewhat lower than conventional CTC with laxative bowel preparation.<xref ref-type="bibr" rid="article-19722.r28">[28]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Barium Enema</bold>
</p>
        <p>Either single- or double-contrast is rarely used, and neither is recommended by any other expert group due to its poor screening indices and the advent of better endoscopic and CTC procedures with better results.</p>
        <p>
<bold>Screening Frequencies and Ideal Intervals for Surveillance and Follow-up&#x000a0;</bold>
</p>
        <p><bold>Guaiac FOBT and F</bold><bold>ecal Immune-chemical Test </bold>&#x000a0;</p>
        <p>Frequency of testing: Experts recommend sigmoidoscopy every 5 years for people at average risk who have had&#x000a0;negative test results.<xref ref-type="bibr" rid="article-19722.r34">[34]</xref></p>
        <p>
<bold>Stool DNA Test</bold>
</p>
        <p>Frequency of testing:&#x000a0;The current recommendation is once every 3 years. If positive on any of the occasions, endoscopic studies such as colonoscopy and sigmoidoscopy are recommended.<xref ref-type="bibr" rid="article-19722.r1">[1]</xref>&#x000a0;</p>
        <p>
<bold>Sigmoidoscopy</bold>
</p>
        <p>Screening frequency:&#x000a0;Sigmoidoscopy should be performed at 5-year intervals from baseline intervention, with gFOBT/FIT every 3 years.<xref ref-type="bibr" rid="article-19722.r1">[1]</xref><xref ref-type="bibr" rid="article-19722.r24">[24]</xref>&#x000a0;</p>
        <p>
<bold>Colonoscopy</bold>
</p>
        <p>Screening&#x000a0;frequency:&#x000a0;Patients&#x000a0;undergoing&#x000a0;colonoscopy should have a 10-year interval between&#x000a0;screening colonoscopies if the examination is negative and of adequate quality.<xref ref-type="bibr" rid="article-19722.r1">[1]</xref><xref ref-type="bibr" rid="article-19722.r36">[36]</xref></p>
        <p>
<bold>Computed Tomography Colonography</bold>
</p>
        <p><bold>Screening frequency: </bold>Current USPSTF recommends CTC<bold>&#x000a0;</bold>every 5 years from baseline CTC or optical colonoscopy.&#x000a0;</p>
      </sec>
      <sec id="article-19722.s4">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19722&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19722">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/19722/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=19722">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-19722.s5">
        <title>References</title>
        <ref id="article-19722.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>US Preventive Services Task Force</collab>
              <name>
                <surname>Bibbins-Domingo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Grossman</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Curry</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Davidson</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Epling</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a</surname>
                <given-names>FAR</given-names>
              </name>
              <name>
                <surname>Gillman</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Harper</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Kemper</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Krist</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Kurth</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Landefeld</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Mangione</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Owens</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Phipps</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Pignone</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Siu</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.</article-title>
            <source>JAMA</source>
            <year>2016</year>
            <month>Jun</month>
            <day>21</day>
            <volume>315</volume>
            <issue>23</issue>
            <fpage>2564</fpage>
            <page-range>2564-2575</page-range>
            <pub-id pub-id-type="pmid">27304597</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Issa</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Noureddine</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Colorectal cancer screening: An updated review of the available options.</article-title>
            <source>World J Gastroenterol</source>
            <year>2017</year>
            <month>Jul</month>
            <day>28</day>
            <volume>23</volume>
            <issue>28</issue>
            <fpage>5086</fpage>
            <page-range>5086-5096</page-range>
            <pub-id pub-id-type="pmid">28811705</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bailey</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>You</surname>
                <given-names>YN</given-names>
              </name>
              <name>
                <surname>Bednarski</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Rodriguez-Bigas</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Skibber</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Cantor</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010.</article-title>
            <source>JAMA Surg</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>150</volume>
            <issue>1</issue>
            <fpage>17</fpage>
            <page-range>17-22</page-range>
            <pub-id pub-id-type="pmid">25372703</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Troisi</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Freedman</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Devesa</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Incidence of colorectal carcinoma in the U.S.: an update of trends by gender, race, age, subsite, and stage, 1975-1994.</article-title>
            <source>Cancer</source>
            <year>1999</year>
            <month>Apr</month>
            <day>15</day>
            <volume>85</volume>
            <issue>8</issue>
            <fpage>1670</fpage>
            <page-range>1670-6</page-range>
            <pub-id pub-id-type="pmid">10223559</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jessup</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>McGinnis</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Steele</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Menck</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Winchester</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <article-title>The National Cancer Data Base. Report on colon cancer.</article-title>
            <source>Cancer</source>
            <year>1996</year>
            <month>Aug</month>
            <day>15</day>
            <volume>78</volume>
            <issue>4</issue>
            <fpage>918</fpage>
            <page-range>918-26</page-range>
            <pub-id pub-id-type="pmid">8756390</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Th&#x000f6;rn</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bergstr&#x000f6;m</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kressner</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Spar&#x000e9;n</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zack</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ekbom</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Trends in colorectal cancer incidence in Sweden 1959-93 by gender, localization, time period, and birth cohort.</article-title>
            <source>Cancer Causes Control</source>
            <year>1998</year>
            <month>Mar</month>
            <volume>9</volume>
            <issue>2</issue>
            <fpage>145</fpage>
            <page-range>145-52</page-range>
            <pub-id pub-id-type="pmid">9578291</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doubeni</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Corley</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Quinn</surname>
                <given-names>VP</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Zauber</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Goodman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Becerra</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Schottinger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Doria-Rose</surname>
                <given-names>VP</given-names>
              </name>
              <name>
                <surname>Levin</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Fletcher</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study.</article-title>
            <source>Gut</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>67</volume>
            <issue>2</issue>
            <fpage>291</fpage>
            <page-range>291-298</page-range>
            <pub-id pub-id-type="pmid">27733426</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yurgelun</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Kulke</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Fuchs</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Allen</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Uno</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hornick</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Ukaegbu</surname>
                <given-names>CI</given-names>
              </name>
              <name>
                <surname>Brais</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>McNamara</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Mayer</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Schrag</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Meyerhardt</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Ng</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kidd</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hartman</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Wenstrup</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Syngal</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.</article-title>
            <source>J Clin Oncol</source>
            <year>2017</year>
            <month>Apr</month>
            <day>01</day>
            <volume>35</volume>
            <issue>10</issue>
            <fpage>1086</fpage>
            <page-range>1086-1095</page-range>
            <pub-id pub-id-type="pmid">28135145</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davis</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Marcet</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Frattini</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Prather</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Mateka</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Nfonsam</surname>
                <given-names>VN</given-names>
              </name>
            </person-group>
            <article-title>Is it time to lower the recommended screening age for colorectal cancer?</article-title>
            <source>J Am Coll Surg</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>213</volume>
            <issue>3</issue>
            <fpage>352</fpage>
            <page-range>352-61</page-range>
            <pub-id pub-id-type="pmid">21737316</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ziogas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Horick</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Kinney</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Lowery</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Domchek</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Isaacs</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Griffin</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Moorman</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Berg</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Tomlinson</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Anton-Culver</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Strong</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Kasten</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Finkelstein</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Plon</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Clinically relevant changes in family history of cancer over time.</article-title>
            <source>JAMA</source>
            <year>2011</year>
            <month>Jul</month>
            <day>13</day>
            <volume>306</volume>
            <issue>2</issue>
            <fpage>172</fpage>
            <page-range>172-8</page-range>
            <pub-id pub-id-type="pmid">21750294</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yamada</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Komaki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Komaki</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Micic</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zullow</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sakuraba</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis.</article-title>
            <source>Lancet Oncol</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>19</volume>
            <issue>6</issue>
            <fpage>758</fpage>
            <page-range>758-767</page-range>
            <pub-id pub-id-type="pmid">29706374</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yuhara</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Steinmaus</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Corley</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Tei</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Buffler</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer?</article-title>
            <source>Am J Gastroenterol</source>
            <year>2011</year>
            <month>Nov</month>
            <volume>106</volume>
            <issue>11</issue>
            <fpage>1911</fpage>
            <page-range>1911-21; quiz 1922</page-range>
            <pub-id pub-id-type="pmid">21912438</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Machalek</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Poynten</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jin</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fairley</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Farnsworth</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Garland</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Hillman</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Petoumenos</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tabrizi</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Templeton</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Grulich</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis.</article-title>
            <source>Lancet Oncol</source>
            <year>2012</year>
            <month>May</month>
            <volume>13</volume>
            <issue>5</issue>
            <fpage>487</fpage>
            <page-range>487-500</page-range>
            <pub-id pub-id-type="pmid">22445259</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rabeneck</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Paszat</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Hilsden</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Saskin</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Leddin</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Grunfeld</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wai</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Goldwasser</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sutradhar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Stukel</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice.</article-title>
            <source>Gastroenterology</source>
            <year>2008</year>
            <month>Dec</month>
            <volume>135</volume>
            <issue>6</issue>
            <fpage>1899</fpage>
            <page-range>1899-1906, 1906.e1</page-range>
            <pub-id pub-id-type="pmid">18938166</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Robertson</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Boland</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Dominitz</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Giardiello</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Kaltenbach</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lieberman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Levin</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Rex</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <article-title>Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.</article-title>
            <source>Gastroenterology</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>152</volume>
            <issue>5</issue>
            <fpage>1217</fpage>
            <page-range>1217-1237.e3</page-range>
            <pub-id pub-id-type="pmid">27769517</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Collins</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Lieberman</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Durbin</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>DG</given-names>
              </name>
              <collab>Veterans Affairs Cooperative Study #380 Group</collab>
            </person-group>
            <article-title>Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice.</article-title>
            <source>Ann Intern Med</source>
            <year>2005</year>
            <month>Jan</month>
            <day>18</day>
            <volume>142</volume>
            <issue>2</issue>
            <fpage>81</fpage>
            <page-range>81-5</page-range>
            <pub-id pub-id-type="pmid">15657155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Robertson</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Boland</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Dominitz</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Giardiello</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Kaltenbach</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lieberman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Levin</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Rex</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <article-title>Recommendations on fecal immunochemical testing to screen for&#x000a0;colorectal neoplasia: a consensus statement by the US Multi-Society Task Force on colorectal cancer.</article-title>
            <source>Gastrointest Endosc</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>85</volume>
            <issue>1</issue>
            <fpage>2</fpage>
            <page-range>2-21.e3</page-range>
            <pub-id pub-id-type="pmid">27769516</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Imperiale</surname>
                <given-names>TF</given-names>
              </name>
              <name>
                <surname>Ransohoff</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Itzkowitz</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Turnbull</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Ross</surname>
                <given-names>ME</given-names>
              </name>
              <collab>Colorectal Cancer Study Group</collab>
            </person-group>
            <article-title>Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.</article-title>
            <source>N Engl J Med</source>
            <year>2004</year>
            <month>Dec</month>
            <day>23</day>
            <volume>351</volume>
            <issue>26</issue>
            <fpage>2704</fpage>
            <page-range>2704-14</page-range>
            <pub-id pub-id-type="pmid">15616205</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ouyang</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Getzenberg</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Schoen</surname>
                <given-names>RE</given-names>
              </name>
            </person-group>
            <article-title>Noninvasive testing for colorectal cancer: a review.</article-title>
            <source>Am J Gastroenterol</source>
            <year>2005</year>
            <month>Jun</month>
            <volume>100</volume>
            <issue>6</issue>
            <fpage>1393</fpage>
            <page-range>1393-403</page-range>
            <pub-id pub-id-type="pmid">15929776</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elmunzer</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Hayward</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Schoenfeld</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Saini</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Deshpande</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Waljee</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials.</article-title>
            <source>PLoS Med</source>
            <year>2012</year>
            <volume>9</volume>
            <issue>12</issue>
            <fpage>e1001352</fpage>
            <pub-id pub-id-type="pmid">23226108</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schoen</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Pinsky</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Weissfeld</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Yokochi</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Church</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Laiyemo</surname>
                <given-names>AO</given-names>
              </name>
              <name>
                <surname>Bresalier</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Andriole</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Buys</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Crawford</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Fouad</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Isaacs</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Reding</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Carrick</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Riley</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Purdue</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Izmirlian</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kramer</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Gohagan</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Prorok</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Berg</surname>
                <given-names>CD</given-names>
              </name>
              <collab>PLCO Project Team</collab>
            </person-group>
            <article-title>Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.</article-title>
            <source>N Engl J Med</source>
            <year>2012</year>
            <month>Jun</month>
            <day>21</day>
            <volume>366</volume>
            <issue>25</issue>
            <fpage>2345</fpage>
            <page-range>2345-57</page-range>
            <pub-id pub-id-type="pmid">22612596</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Atkin</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kralj-Hans</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Wooldrage</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hart</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Northover</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Parkin</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Wardle</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Duffy</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Cuzick</surname>
                <given-names>J</given-names>
              </name>
              <collab>UK Flexible Sigmoidoscopy Trial Investigators</collab>
            </person-group>
            <article-title>Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial.</article-title>
            <source>Lancet</source>
            <year>2010</year>
            <month>May</month>
            <day>08</day>
            <volume>375</volume>
            <issue>9726</issue>
            <fpage>1624</fpage>
            <page-range>1624-33</page-range>
            <pub-id pub-id-type="pmid">20430429</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Piper</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Perdue</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Rutter</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Webber</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>O'Connor</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Whitlock</surname>
                <given-names>EP</given-names>
              </name>
            </person-group>
            <article-title>Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.</article-title>
            <source>JAMA</source>
            <year>2016</year>
            <month>Jun</month>
            <day>21</day>
            <volume>315</volume>
            <issue>23</issue>
            <fpage>2576</fpage>
            <page-range>2576-94</page-range>
            <pub-id pub-id-type="pmid">27305422</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brenner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Stock</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hoffmeister</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies.</article-title>
            <source>BMJ</source>
            <year>2014</year>
            <month>Apr</month>
            <day>09</day>
            <volume>348</volume>
            <fpage>g2467</fpage>
            <pub-id pub-id-type="pmid">24922745</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Rijn</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Reitsma</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Stoker</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bossuyt</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>van Deventer</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Dekker</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Polyp miss rate determined by tandem colonoscopy: a systematic review.</article-title>
            <source>Am J Gastroenterol</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>101</volume>
            <issue>2</issue>
            <fpage>343</fpage>
            <page-range>343-50</page-range>
            <pub-id pub-id-type="pmid">16454841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pickhardt</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Nugent</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Mysliwiec</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Schindler</surname>
                <given-names>WR</given-names>
              </name>
            </person-group>
            <article-title>Location of adenomas missed by optical colonoscopy.</article-title>
            <source>Ann Intern Med</source>
            <year>2004</year>
            <month>Sep</month>
            <day>07</day>
            <volume>141</volume>
            <issue>5</issue>
            <fpage>352</fpage>
            <page-range>352-9</page-range>
            <pub-id pub-id-type="pmid">15353426</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rex</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Adler</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Aisenberg</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Burch</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Carretero</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chowers</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Fein</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Fern</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Fernandez-Urien Sainz</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Fich</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gal</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Horlander</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Isaacs</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Kariv</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lahat</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Leung</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Malik</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Papageorgiou</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Romeo</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Waterman</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Accuracy of capsule colonoscopy in detecting colorectal polyps in a screening population.</article-title>
            <source>Gastroenterology</source>
            <year>2015</year>
            <month>May</month>
            <volume>148</volume>
            <issue>5</issue>
            <fpage>948</fpage>
            <page-range>948-957.e2</page-range>
            <pub-id pub-id-type="pmid">25620668</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zalis</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Blake</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Cai</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Hahn</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Halpern</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Kazam</surname>
                <given-names>IG</given-names>
              </name>
              <name>
                <surname>Keroack</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Magee</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>N&#x000e4;ppi</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Perez-Johnston</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Saltzman</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Vij</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yee</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yoshida</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic accuracy of laxative-free computed tomographic colonography for detection of adenomatous polyps in asymptomatic adults: a prospective evaluation.</article-title>
            <source>Ann Intern Med</source>
            <year>2012</year>
            <month>May</month>
            <day>15</day>
            <volume>156</volume>
            <issue>10</issue>
            <fpage>692</fpage>
            <page-range>692-702</page-range>
            <pub-id pub-id-type="pmid">22586008</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iannaccone</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Laghi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Catalano</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mangiapane</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lamazza</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schillaci</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sinibaldi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Murakami</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sammartino</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hori</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Piacentini</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Nofroni</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Stipa</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Passariello</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Computed tomographic colonography without cathartic preparation for the detection of colorectal polyps.</article-title>
            <source>Gastroenterology</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>127</volume>
            <issue>5</issue>
            <fpage>1300</fpage>
            <page-range>1300-11</page-range>
            <pub-id pub-id-type="pmid">15520999</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johnson</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Barclay</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Mergener</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>K&#x000f6;nig</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Beck</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Potter</surname>
                <given-names>NT</given-names>
              </name>
            </person-group>
            <article-title>Plasma Septin9 versus fecal immunochemical testing for colorectal cancer screening: a prospective multicenter study.</article-title>
            <source>PLoS One</source>
            <year>2014</year>
            <volume>9</volume>
            <issue>6</issue>
            <fpage>e98238</fpage>
            <pub-id pub-id-type="pmid">24901436</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>YQ</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Hang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sheng</surname>
                <given-names>JQ</given-names>
              </name>
            </person-group>
            <article-title>Performance of a second-generation methylated SEPT9 test in detecting colorectal neoplasm.</article-title>
            <source>J Gastroenterol Hepatol</source>
            <year>2015</year>
            <month>May</month>
            <volume>30</volume>
            <issue>5</issue>
            <fpage>830</fpage>
            <page-range>830-3</page-range>
            <pub-id pub-id-type="pmid">25471329</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Rossum</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>van Rijn</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>van Oijen</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Fockens</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Laheij</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Verbeek</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Jansen</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Dekker</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening.</article-title>
            <source>Int J Cancer</source>
            <year>2009</year>
            <month>Aug</month>
            <day>15</day>
            <volume>125</volume>
            <issue>4</issue>
            <fpage>746</fpage>
            <page-range>746-50</page-range>
            <pub-id pub-id-type="pmid">19408302</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Duffy</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>van Rossum</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>van Turenhout</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Malminiemi</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Sturgeon</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lamerz</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nicolini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Haglund</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Holubec</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fraser</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Halloran</surname>
                <given-names>SP</given-names>
              </name>
            </person-group>
            <article-title>Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper.</article-title>
            <source>Int J Cancer</source>
            <year>2011</year>
            <month>Jan</month>
            <day>01</day>
            <volume>128</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-11</page-range>
            <pub-id pub-id-type="pmid">20824704</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hol</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>van Leerdam</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>van Ballegooijen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>van Vuuren</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>van Dekken</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Reijerink</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>van der Togt</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Habbema</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Kuipers</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <article-title>Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.</article-title>
            <source>Gut</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>59</volume>
            <issue>1</issue>
            <fpage>62</fpage>
            <page-range>62-8</page-range>
            <pub-id pub-id-type="pmid">19671542</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zapka</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Klabunde</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Taplin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yuan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ransohoff</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kobrin</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Screening colonoscopy in the US: attitudes and practices of primary care physicians.</article-title>
            <source>J Gen Intern Med</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>27</volume>
            <issue>9</issue>
            <fpage>1150</fpage>
            <page-range>1150-8</page-range>
            <pub-id pub-id-type="pmid">22539065</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19722.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Turner</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Xue</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Targownik</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Bernstein</surname>
                <given-names>CN</given-names>
              </name>
            </person-group>
            <article-title>Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies.</article-title>
            <source>JAMA</source>
            <year>2006</year>
            <month>May</month>
            <day>24</day>
            <volume>295</volume>
            <issue>20</issue>
            <fpage>2366</fpage>
            <page-range>2366-73</page-range>
            <pub-id pub-id-type="pmid">16720822</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
